Exploring the role of Microbiome in Susceptibility, Treatment Response and Outcome among Tuberculosis Patients from Pakistan: study protocol for a prospective cohort study (Micro-STOP)

Muhammad Shahzad, Simon C Andrews, Zia Ul-Haq, Muhammad Shahzad, Simon C Andrews, Zia Ul-Haq

Abstract

Introduction: Tuberculosis (TB) caused by Mycobacterium tuberculosis is a common infectious disease associated with significant morbidity and mortality, especially in low-income and middle-income countries. Successful treatment of the disease requires prolonged intake (6-8 months) of multiple antibiotics with potentially detrimental consequences on the composition and functional potential of the human microbiome. The protocol described in the current study aims to identify microbiome (oral and gut) signatures associated with TB pathogenesis, treatment response and outcome in humans.

Methods and analysis: Four hundred and fifty, newly diagnosed patients with TB from three district levels (Peshawar, Mardan and Swat) TB diagnosis and treatment centres, will be recruited in this non-interventional, prospective cohort study and will be followed and monitored until treatment completion. Demographic and dietary intake data, anthropometric measurement and blood, stool and salivary rinse samples will be collected at baseline, day 15, month-2 and end of the treatment. Additionally, we will recruit age (±3 years) and sex-matched healthy controls (n=30). Blood sampling will allow monitoring of the immune response during the treatment, while salivary rinse and faecal samples will allow monitoring of dynamic changes in oral and gut microbiome diversity. Within this prospective cohort study, a nested case-control study design will be conducted to assess perturbations in oral and gut microbiome diversity (microbial dysbiosis) and immune response and compare between the patients groups (treatment success vs failure).

Ethics and dissemination: The study has received ethics approval from the Ethic Board of Khyber Medical University Peshawar, and administrative approval from Provincial TB Control Programme of Khyber Pakhtunkhwa, Pakistan. The study results will be presented in national and international conferences and published in peer-reviewed journals.

Trial registration number: NCT04985994.

Keywords: Diagnostic microbiology; MICROBIOLOGY; NUTRITION & DIETETICS; Protocols & guidelines; Respiratory infections; Tuberculosis.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow chart of the study. TB, tuberculosis.

References

    1. World Health Organization . Global tuberculosis report 2020 [Internet]. Geneva, Switzerland, 2020. Available:
    1. Cohen A, Mathiasen VD, Schön T, et al. . The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J 2019;54:1900655. 10.1183/13993003.00655-2019
    1. Jilani TN, Avula A, Zafar Gondal A, et al. . Active Tuberculosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2021.
    1. Naidoo CC, Nyawo GR, Wu BG, et al. . The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda. Lancet Respir Med 2019;7:892–906. 10.1016/S2213-2600(18)30501-0
    1. Orme IM, Robinson RT, Cooper AM. The balance between protective and pathogenic immune responses in the TB-infected lung. Nat Immunol 2015;16:57–63. 10.1038/ni.3048
    1. Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2015;5:CD003343. 10.1002/14651858.CD003343.pub4
    1. Orenstein EW, Basu S, Shah NS, et al. . Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009;9:153–61. 10.1016/S1473-3099(09)70041-6
    1. Shuldiner J, Leventhal A, Chemtob D, et al. . Mortality after anti-tuberculosis treatment completion: results of long-term follow-up. Int J Tuberc Lung Dis 2016;20:43–8. 10.5588/ijtld.14.0427
    1. Humbwavali JB, Trujillo NJ, Paim BS, et al. . Sputum monitoring during tuberculosis treatment for predicting outcome. Lancet Infect Dis 2011;11:160. 10.1016/S1473-3099(11)70043-3
    1. Barry CE, Boshoff HI, Dartois V, et al. . The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009;7:845–55. 10.1038/nrmicro2236
    1. Mori G, Morrison M, Blumenthal A. Microbiome-immune interactions in tuberculosis. PLoS Pathog 2021;17:e1009377. 10.1371/journal.ppat.1009377
    1. Gilbert JA, Blaser MJ, Caporaso JG, et al. . Current understanding of the human microbiome. Nat Med 2018;24:392–400. 10.1038/nm.4517
    1. The Cost of Sequencing a Human Genome [Internet]. . Available: [Accessed 29 Sep 2021].
    1. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007;449:811–8. 10.1038/nature06245
    1. Hacquard S, Garrido-Oter R, González A, et al. . Microbiota and host nutrition across plant and animal kingdoms. Cell Host Microbe 2015;17:603–16. 10.1016/j.chom.2015.04.009
    1. Lynch JB, Hsiao EY. Microbiomes as sources of emergent host phenotypes. Science 2019;365:1405–9. 10.1126/science.aay0240
    1. Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492–506. 10.1038/s41422-020-0332-7
    1. Qin J, Li Y, Cai Z, et al. . A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55–60. 10.1038/nature11450
    1. Million M, Diallo A, Raoult D. Gut microbiota and malnutrition. Microb Pathog 2017;106:127–38. 10.1016/j.micpath.2016.02.003
    1. Dubourg G, Lagier JC, Armougom F, et al. . The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics. Eur J Clin Microbiol Infect Dis 2013;32:637–45. 10.1007/s10096-012-1787-3
    1. Winglee K, Eloe-Fadrosh E, Gupta S, et al. . Aerosol Mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiota. PLoS One 2014;9:e97048. 10.1371/journal.pone.0097048
    1. Hu Y, Feng Y, Wu J, et al. . The gut microbiome signatures discriminate healthy from pulmonary tuberculosis patients. Front Cell Infect Microbiol 2019;9:90. 10.3389/fcimb.2019.00090
    1. Segal LN, Clemente JC, Li Y, et al. . Anaerobic bacterial fermentation products increase tuberculosis risk in Antiretroviral-Drug-Treated HIV patients. Cell Host Microbe 2017;21:530–7. 10.1016/j.chom.2017.03.003
    1. Perry S, de Jong BC, Solnick JV, et al. . Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 2010;5:e8804. 10.1371/journal.pone.0008804
    1. Ardura MI, Banchereau R, Mejias A, et al. . Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS One 2009;4:e5446. 10.1371/journal.pone.0005446
    1. Chandra TJ, Alan RR, Selvaraj R, et al. . MODS assay for rapid diagnosis of tuberculosis among HIV TB CO infected individuals in a tertiary care Hospital, Andhra Pradesh. Pak J Chest Med 2014;20.
    1. Boehme CC, Nabeta P, Hillemann D, et al. . Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005–15. 10.1056/NEJMoa0907847
    1. National TB Control Program . National Institute of health Islamabad. Available: [Accessed 20 Apr 2022].
    1. Lewinsohn DM, Leonard MK, LoBue PA, et al. . Official American thoracic Society/Infectious diseases Society of America/Centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 2017;64:e1–33. 10.1093/cid/ciw694
    1. Shim J-S, Oh K, Kim HC. Dietary assessment methods in epidemiologic studies. Epidemiol Health 2014;36:e2014009. 10.4178/epih/e2014009
    1. Woo JS, Lu DY,. Procurement, transportation, and storage of saliva, buccal swab, and oral wash specimens. Methods Mol Biol 2019;1897:99–105. 10.1007/978-1-4939-8935-5_10
    1. Zheng W, Tsompana M, Ruscitto A, et al. . An accurate and efficient experimental approach for characterization of the complex oral microbiota. Microbiome 2015;3:48. 10.1186/s40168-015-0110-9
    1. Bolker BM, Brooks ME, Clark CJ, et al. . Generalized linear mixed models: a practical guide for ecology and evolution. Trends Ecol Evol 2009;24:127–35. 10.1016/j.tree.2008.10.008
    1. Parks DH, Tyson GW, Hugenholtz P, et al. . Stamp: statistical analysis of taxonomic and functional profiles. Bioinformatics 2014;30:3123–4. 10.1093/bioinformatics/btu494
    1. Makarenkov V, Legendre P. Nonlinear redundancy analysis and canonical correspondence analysis based on polynomial regression. Ecology 2002;83:1146–61. 10.1890/0012-9658(2002)083[1146:NRAACC];2

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren